Deep Medicine Acquisition... (DMAQ)
2.96
-5.43 (-64.72%)
At close: Jan 31, 2024, 9:00 PM
Company Description
Deep Medicine Acquisition Corp. does not have significant operations.
The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
It focuses on identifying businesses in the healthcare industry.
The company was incorporated in 2020 and is based in New York, New York.
Deep Medicine Acquisition Corp.
| Country | United States |
| IPO Date | Dec 2, 2021 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | 2 |
| CEO | Humphrey P. Polanen |
Contact Details
Address: 595 Madison Avenue New York, New York United States | |
| Website | n/a |
Stock Details
| Ticker Symbol | DMAQ |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001857086 |
| CUSIP Number | 243733102 |
| ISIN Number | US2437331026 |
| Employer ID | 85-3269086 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Humphrey P. Polanen | Chief Executive Officer & Chairman of the Board |
| Weixuan Luo CPA, MS | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 15, 2025 | 10-K | Annual Report |
| Apr 04, 2025 | 8-K | Current Report |
| Mar 31, 2025 | NT 10-K | Filing |
| Feb 19, 2025 | 8-K | Current Report |
| Jan 16, 2025 | 8-K | Current Report |
| Jan 08, 2025 | 8-K | Current Report |
| Dec 16, 2024 | 8-K | Current Report |
| Nov 25, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 08, 2024 | 8-K | Current Report |